February 11, 2020 / 12:40 PM / 9 days ago

BRIEF-Crescita Announces Positive Results From Late-Stage Studies For Plaque Psoriasis Therapy

Feb 11 (Reuters) - Crescita Therapeutics Inc:

* CRESCITA ANNOUNCES POSITIVE TOPLINE RESULTS FROM TWO PIVOTAL PHASE 3 CLINICAL STUDIES FOR ITS LEAD PIPELINE PRODUCT IN PATIENTS WITH PLAQUE PSORIASIS

* CRESCITA THERAPEUTICS INC - PRIMARY ENDPOINT ACHIEVED WITH HIGH STATISTICAL SIGNIFICANCE IN TRIAL

* CRESCITA THERAPEUTICS INC - BOTH PHASE 3 STUDIES MET PRIMARY ENDPOINT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below